Congress details and information
- SBFTE Art and Science Exhibition (Exposição de Arte e Ciência – SBFTE)
- Promoting Pharmacology in Primary Public Schools in Balneário Camboriú (SBFTE e Divulgação de Farmacologia na Escola Pública)
- 07-08/10/2024 – II National Pain Symposium: Addressing Challenges and Innovations in Lifespan Pain Management
- SBFTE Jovem Assembly
- SBFTE Assembly
- Meeting of the Board of SBFTE Directors and Deliberative Council (Council and Directory Board Members only)
- Meeting of SBFTE Permanent Forum of Graduate Courses in Pharmacology
- Meeting of the North-Northeast and Central West Region Pharmacology Network
- Meet the Professor
- José Ribeiro do Valle Award
- Women in Pharmacology in Brazil Award – 2024 Edition
Pré-Congress Course
Learning the Discovery and Development Process of New Drugs and Medicines with the Screener Educational Game (Aprendendo o Processo de Descoberta e Desenvolvimento de novos Fármacos e Medicamentos com o Jogo Educacional Screener)
Chair: François G. Noel (UFRJ) (Presented in Portuguese)
Vagas Limitadas: 12 participantes
Segunda 07/10/2024
Manhã: 09h00-12h00
Tarde: 13h00-17h00
Requisitos:
- Tem que estar inscrito no Congresso
- Para receber o Certificado o inscrito deverá estar presente ao curso desde o início
- Enviar carta de intenção para o E-mail sbfte@sbfte.org.br, identificando no assunto “Curso Pré-Congresso SBFTE 2024”, no momento da inscrição no congresso
Carta de Intenção (máximo 300 palavras) especificando:
- Nome Completo
- Formação (Iniciação Científica, Aluno de Pós-Graduação (Mestrado / Doutorado), Pós-Doc ou Docente
- Instituição de Origem
- Área de atuação:
- Tipo de pesquisa desenvolvida:
- Área(s): (p.ex.: Química Medicinal, Farmacocinética, Farmacodinâmica in vitro, Farmacodinâmica in vivo, Toxicologia, Farmacologia Clínica etc.):
- Motivação para este curso (explicar porque este treinamento seria importante para sua formação/pesquisa ou uso na docência)
Courses
Cr1 – Reliability, Transparency, And Quality: Tips from Obtaining Data To Completion (Confiabilidade, Transparência e Qualidade: Dicas desde a Obtenção dos Dados até a Conclusão)
Chair: Janaína Menezes Zanoveli (UFPR)
- Class 1: Power of the test x n sample (focus on the 3 R’s): approach to its importance in the design of studies (Poder do teste x n amostral (foco nos 3 R´s): abordagem sobre sua importância no delineamento dos estudos)
Janaina Menezes Zanoveli (UFPR)
- Class 2: Guidelines for reporting methodologies in animal experimentation: Have you ARRIVEd there yet? (Diretrizes para relatar metodologias em experimentação animal: Have you ARRIVEd there yet?)
Quelen Iane Garlet (UFPR)
- Reproducibility crisis: possible causes, consequences and how we can get around them (Crise de reprodutibilidade: possíveis causas, consequências e como podemos contorná-las)
Janaína Menezes Zanoveli (UFPR)
Cr2 – Experimental Models of Autism Spectrum Disorder (ASD) and Attention Deficit Hyperactivity Disorder (ADHD): Focus on Discovering new Therapeutic Targets (Modelos Experimentais dos Transtornos Do Espectro Autista (TEA) e Déficit de Atenção e Hiperatividade (TDAH): Foco na Descoberta de Novos Alvos Terapêuticos)
Chair: Luisa Mota da Silva (UFSC)
- Class 1: Experimental models of ASD and the possibilities of new therapeutic strategies exploring the gut-brain connection (Modelos experimentais de TEA e a possibilidades de novas estratégias terapêuticas explorando a conexão intestino-cérebro)
Luisa Mota da Silva (UFSC) - Class 2: Maternal immune activation as an experimental model in the search for therapeutic targets in the study of ASD (Ativação imune materna como modelo experimental na busca de alvos terapêuticos no estudo do TEA)
Alexandre Giusti Paiva (UFSC) - Class 3: Experimental models of ADHD: unraveling neurobiology and new therapeutic targets (Modelos experimentais de TDAH: desvendando a neurobiologia e novos alvos terapêuticos)
Rui Daniel Schröder Prediger (UFSC)
Cr3 – How to Build a Vascular Aging Model: From Molecular Targets to Pharmacological Tools. (Como criar Modelos de Envelhecimento Vascular: De Alvos Moleculares às Ferramentas Farmacológicas)
Chair: Paulo de Assis Melo (UFRJ)
- Class 1: From the concept of cellular aging to the development of in vitro and in vivo models for identifying pharmacological targets (Desde o conceito de envelhecimento celular até o desenvolvimento de modelos in vitro e in vivo para identificação de alvos farmacológicos)
Lucienne da Silva Lara Morcillo (UFRJ) - Class 2: Understanding the role of mitochondria and reactive oxygen species signaling in a vascular accelerated aging animal model (Compreendendo o papel da sinalização de espécies reativas de oxigênio e das mitocôndrias em um modelo animal de envelhecimento vascular acelerado)
Sabrina Ribeiro Gonsalez (Erasmus University/UFRJ) - Class 3: Exploring a new pharmacological approach to combat aging of the vasculature: focusing on the nitric oxide – cGMP signaling pathway and novel mitochondrial regulator compounds (Novas ferramentas farmacológicas para combater o envelhecimento vascular: foco em compostos que atuam nas sinalizações mediadas por óxido nítrico – cGMP e nas mitocondrias)
Anton Roks (Erasmus University, The Netherlands)
Lectures
L1 – Rocha e Silva Memorial Lecture Calcitonin Gene-Related Peptide (CGRP) agonists protects against remodeling in heart failure Susan D. Brain (King´s College London, UK)
L2 – d-Amino Acids: New Clinical Pathways for Brain Diseases Jean-Pierre Mothet (Université Paris-Saclay, France)
L3 – Pharmacology 2.0: Advanced Models for the Development of New Therapies of Age Related Inflammatory Diseases Martina Schmidt (University of Groningen, The Netherlands)
L4 – Pain and Innate Immune Memory: Do they Share Similar Mechanisms? Christophe Altier (University of Calgary, Canada)
L5 – Effects of Sweetener Chronic Consumption on Brain Neurotransmission and Cognition Sylvie Granon (Paris-Saclay Institute of Neuroscience, France)
L6 – Bioportide Technologies: New Biological Agents and a Platform for Drug Discovery John Howl (Birmingham City University, UK)
L7 – Generation of Natural Product Libraries for High Throughput Screening Tanja Grkovic (National Institute of Health, USA)
L8 – miRNA therapeutics: lessons from development of miR125b* and miR450a for cardioprotection Péter Ferdinandy (Semmelweis University, Hungary)
Symposia
S1 – Pharmacology Without Borders: Emerging Technologies and Trends from British and Brazilian Pharmacology Societies
Drug Discovery and Therapeutic Innovation for the Treatment of COPD: Translating Basic Respiratory Pharmacology into Clinical Practice
Chair: Marco Aurelio Martins (Fiocruz) & Clive Page (King´s College, UK)
- The burden of unmet needs in COPD
Wisia Wedzicha (Imperial College London, UK) - Use of preclinical models to investigate novel drugs for the treatment of respiratory diseases
Marco Aurelio Martins (Fiocruz) - Early experimental medicine studies for investigating new drugs for COPD
Dave Singh (University of Manchester, UK) - My adventures with developing novel drugs for the treatment of respiratory diseases
Clive Page (King´s College, UK)
S2 – The Excitatory-Inhibitory Balance as a Target to treat Mental Disorders
Chair: Felipe Villela Gomes (USP-RP)
- Excitatory-inhibitory mechanisms in stress-related models: a target for pharmacological intervention
Marco Andrea Riva (University of Milan, Italy) - Fixing broken synapses: glutamatergic and GABAergic dysfunction in depression and reversal by novel treatments
Manoela Viar Fogaça (University of Rochester, USA) - Biomarkers that capture excitation-inhibition imbalance in humans
Patricio O’Donnell (Sage Therapeutics, USA) - Oral Presentation 1:
- Oral Presentation 2:
S3 – Redox Opportunities in the Treatment of Cardiovascular Diseases
Chair: Lucia Rossetti Lopes (USP-SP)
- Poldip2 controls brain vascular permeability by regulating ROS-mediated tight junction phosphorylation and localization at the interendothelial border
Marina Sorrentino Hernandes (Emory University, USA) - Endoplasmic Reticulum Chaperones in Intercellular Redox Communication
Francisco Rafael Martins Laurindo (InCor-HC-FMUSP) - Protein Disulfide isomerase and Nox: novel redox therapeutic targets in the treatment of hypertension
Lucia Rossetti Lopes (USP-SP) - Oral Presentation 1:
- Oral Presentation 2:
S4 – Targeting Metabolic Dysfunctions and Obesity: New Approaches and Insights
Chair: Luciene Bruno Vieira (UFMG)
- Effects of dietary fiber on intestinal microbiota and behavioral and neurobiochemical changes in a murine model of Huntington’s Disease
Fabíola Mara Ribeiro (UFMG) - Metabolic Programming of obesity: can prevention be achieved?
Cristiane Matté (UFRGS) - Mechanisms by which chronic hyperpalatable diet may induce cognitive alterations
Luciene Bruno Vieira (UFMG) - Oral Presentation 1:
- Oral Presentation 2:
S5 – Cellular Plasticity in Inflammation
Chair: João Alfredo de Moraes (UFRJ)
- Cellular and transcriptional dynamics in neutrophil maturation and activation
Nicola Tamassia (University of Verona, Italy) - Neutrophil Extracellular Traps (NETS) support cancer progression by induction of chemoresistant phenotypes
Robson de Queiroz Monteiro (UFRJ) - Effect of tumor extracellular vesicles on neutrophil polarization
João Alfredo de Moraes (UFRJ) - Integrative approach to determine mechanisms and novel therapeutic targets for difficult-to-treat rheumatoid arthritis patients
- Zsuzsanna Helyes (Pécs University, Hungary)
S6 – SGLT2 and GLP1 Drugs Transcend Endocrine Benefits and Produce Cardiovascular and Renal Protection
Chair: José Wilson do Nascimento Corrêa (UFAM)
- Background of SGLT2 inhibitors and GLP1 agonists
José Wilson do Nascimento Corrêa (UFAM) - Cardiovascular and Renal benefits of GLP1 agonists
Adriana Castello Costa Girardi (USP-SP) - Cardiovascular and renal benefits of SGLT2 inhibitors
Coert J. Zuurbier (University of Amsterdam, The Netherlands) - Oral Presentation 1:
- Oral Presentation 2:
S7 – Projecting the Future of Clinical Pharmacological Research in Argentina, Brazil and Chile
Chair: Soraia K P Costa (USP-SP)
- The future of pharmacology: from artificial intelligence to cell therapies
Ventura Simonovich (President of the Argentine Society for Experimental Pharmacology) - An integrated research effort to prevent and treat dengue
Mauro M. Teixeira (UFMG) - From the bench to the patient in the repurposing of old drugs for Chagas disease
Juan Diego Maya (University of Chile, Chile) - Oral Presentation 1:
- Oral Presentation 2:
S8 – Novel Hormonal Treatments for Mood Disorders: The Brain-Gonadal Axis
Chair: Helena Maria Tannhauser Barros (UFCSPA)
- Novel rapid-acting neurosteroid-based antidepressants: new tools for the treatment of mood disorders
Graziano Pinna (University of Illinois at Chicago, USA) - Neurosteroids and ovarian physiology: central and peripheral modulation
Myriam Raquel Laconi (CONICET-University of Mendoza, Argentina) - Neurosteroids and depressive-like phenotype differences based on sex: biomarkers of treatment efficacy
Helena Maria Tannhauser Barros (UFCSPA) - Oral Presentation 1:
- Oral Presentation 2:
S9 – New Targets for Neuropathic Pain and Migraine-Related Pain Relief
Chair: Gabriela Trevisan dos Santos (UFSM)
- Autoantibodies and pain
Stuart Bevan (King´s College London, UK) - Targeting mitochondria for chronic pain relief
Vanessa Olzon Zambelli (IBu) - Contribution of Cav3.2 to migraine-related responses in vivo and in vitro
Juliana Geremias Chichorro (UFPR) - TRPA1 and TRPV4 receptors as a new targets for pain control in multiple sclerosis
Gabriela Trevisan (UFSM)
S10 – PBPK, PBBM, POPPK, POPPKPD, QSP: What Does This Alphabet Soup have to do with Pharmacology?
Chair: Teresa Dalla Costa (UFRGS)
- PBPK models to inform decision making in drug development: from early phases to formulation design
Manuel Ibarra (Universidad de la República, Uruguay) - Where, when, and how can the population pharmacokinetics approach be applied in drug discovery and precision dosing?
Bibiana Verlindo de Araújo (UFRGS) - Quantitative systems pharmacology: Current state and future opportunities
Stephan Schmidt (University of Florida, USA) - Oral Presentation 1:
- Oral Presentation 2:
Roundtables
RT1 – A View on Pharmacology Graduation in Brazil: Perspectives and Challenges (Um Olhar sobre os Pós-graduandos em Farmacologia no Brasil: Perspectivas e Desafios) (Presented in Portuguese)
RT2 – Beyond the Academy (Além da Academia)
Chair: Weverton Castro Coelho-Silva (Coordinator SBFTE Jovem Committee, USP-RP) (Presented in Portuguese)
- To be announced
Fabiano Barreto (MAPA–LFDA-RS) - To be announced
Sandra Milena Bonilla Becerra (Medical Scientific Writer and Scientific Illustrator- Independent) - To be announced
Iasmim Silva de Mello (Thermo Fisher Scientific)
RT3 – Empowering women in Science and Technology: a roundtable discussion on equity
Chair: Patricia M. R. Silva Martins (Fiocruz) & Susan D. Brain (King´s College London, UK) (Presented in English)
- Gender in science and science policy
Marcia Cristina Bernardes Barbosa (Seppe-MCTI) - To be announced
Susan D Brain (King´s College London, UK) - Gender equity in science: the role of scientific societies
Pâmela Billig Mello Carpes (Unipampa) - To be announced